Senior Development Program Lead, Rare Disease

Alnylam Pharmaceuticals, Inc.

United States

Hybrid

USD 210,000 - 310,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Alnylam Pharmaceuticals in the United States is seeking a Program Lead, Development for rare diseases to provide strategic and operational leadership of two early-stage programs. You will drive integrated development strategies, establish milestones, and guide cross-functional teams to execute critical early clinical programs.

The role requires seasoned drug development leadership, ability to navigate ambiguity, and engagement across Research, Clinical Operations, Regulatory Affairs,

Qualifications

  • Advanced degree in medicine, science, pharmacy, or related discipline.
  • 10+ years in biotech/pharma drug development with cross-functional leadership.
  • Rare disease drug development experience preferred.

Responsibilities

  • Lead integrated, cross-functional strategies for early-stage rare disease programs.
  • Establish program vision, milestones, and align scientific, regulatory, operational, and business considerations.
  • Develop fit-for-purpose plans reflecting asset stage, evidence, investment, and future potential.
  • Lead cross-functional teams on proof-of-concept strategies and data requirements.
  • Integrate scientific evidence, clinical data, regulatory considerations, and patient needs into strategy.
  • Translate complex information into clear recommendations and executable plans.
  • Anticipate risks, establish mitigation plans, and escalate issues for timely decisions.
  • Align resources and expertise with program milestones and deliverables.
  • Foster an inclusive, high-performing team and transparent communication.
  • Prepare and present strategy, status, risks, and scenarios to governance and senior leaders.
  • Document decisions, dependencies, and risks across the organization.
  • Champion programs and articulate scientific rationale, patient impact, and development path.

Skills

Cross-functional leadership
Drug development
Rare disease
Strategic planning
Program management
Leadership
Regulatory strategy
Clinical development

Education

MD/PhD/PharmD or equivalent

Job description

Alnylam Pharmaceuticals in the United States is seeking a Program Lead, Development for rare diseases to provide strategic and operational leadership of two early-stage programs. You will drive integrated development strategies, establish milestones, and guide cross-functional teams to execute critical early clinical programs.

The role requires seasoned drug development leadership, ability to navigate ambiguity, and engagement across Research, Clinical Operations, Regulatory Affairs,

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Program Lead - Early-Stage Rare Disease
Senior Program Lead - Early-Stage Rare Disease

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 247,000 - 334,000
Program Lead, Development - Rare Disease
Program Lead, Development - Rare Disease

Alnylam Pharmaceuticals, Inc. • United States

Hybrid
USD 210,000 - 310,000
Program Lead, Development - Rare Disease
Program Lead, Development - Rare Disease

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 247,000 - 334,000
Clinical Development Director, RNAi Therapeutics
Clinical Development Director, RNAi Therapeutics

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 255,000 - 345,000
Comprehensive healthcare benefits
Generous paid time off
401(k) with company match
+2
Director, Clinical Research - RNAi Therapeutics Lead
Director, Clinical Research - RNAi Therapeutics Lead

Alnylam Pharmaceuticals, Inc. • Philadelphia

On-site
USD 255,000 - 345,000
Medical, dental & vision
Life and disability insurance
401(k) with company match
+2
Director, Patient Advocacy & Engagement — Rare Diseases
Director, Patient Advocacy & Engagement — Rare Diseases

Civic Science Media • Boston (MA)

Hybrid
USD 120,000 - 180,000
Senior Director, Nonclinical Toxicology & Strategy
Senior Director, Nonclinical Toxicology & Strategy

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 223,000 - 314,000
Senior Clinical Development Lead - Remote (Rare Disease)
Senior Clinical Development Lead - Remote (Rare Disease)

EPM Scientific • Boston (MA)

Remote
USD 180,000 - 240,000
Director, Clinical Research- Benign Hematology
Director, Clinical Research- Benign Hematology

Alnylam Pharmaceuticals, Inc. • Cambridge (MA), Philadelphia

On-site
USD 260,000 - 380,000
Director, Clinical Research
Director, Clinical Research

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 255,000 - 345,000
Comprehensive healthcare benefits
Generous paid time off
401(k) with company match
+2